2027 Budget Planning: Don’t buy media by logo size. Buy attention.
For advertising directors, brand leaders and VPs of Marketing investing in pharmacy and healthcare media, this is worth examining.
I compared the last 30 days of LinkedIn performance across several of the most recognizable digital media brands serving pharmacy and healthcare:
Becker’s Healthcare — 409,056 followers
Pharmacy Times — 102,700 followers
MJH Life Sciences — 32,769 followers
Pharmacy Podcast Network — 15,600 followers
Drug Topics — 7,896 followers
The scale differences are enormous.
Becker’s and MJH Life Sciences operate sophisticated, multimillion-dollar healthcare media businesses. Pharmacy Times and Drug Topics are established publishing brands backed by a much larger media infrastructure.
Then there is Pharmacy Podcast Network.
We are by far the smaller business economically.
But look at the attention we are generating.
During the last 30 days:
• PPN generated 707 reactions, ranking behind only Becker’s and DSN in the comparison.
• PPN reactions increased 148.1% — substantially faster growth than the major publishers shown.
• PPN generated 37 comments, second only to Becker’s among the brands displayed.
• Comments increased 85%.
• PPN published 75 posts, up 50%.
• PPN added 232 new followers, up 53.6%.
Now normalize some of that activity for audience size.
PPN generated approximately 4.5 reactions for every 100 followers during this period.
Compare that with approximately:
Becker’s: 1.4 per 100 followers
MJH Life Sciences: 1.0 per 100 followers
Pharmacy Times: 0.5 per 100 followers
Drug Topics: 3.5 per 100 followers
That is the metric marketers should be paying attention to.
Audience size tells you potential reach. Audience response tells you whether people are actually paying attention.
And that distinction has major implications for advertising ROI.
Large healthcare publishers carry large organizations, large sales infrastructures, expensive conferences, substantial production operations and significant corporate overhead. Those economics ultimately influence what advertisers pay for access to their audiences.
PPN operates differently.
We are a focused pharmacy media network built around podcasts, video, social distribution, industry relationships, conferences and highly targeted professional audiences.
That creates an opportunity for advertisers to evaluate something far more important than the publisher’s annual revenue:
How much meaningful pharmacy attention am I receiving for every dollar invested?
A $50,000 media package is not automatically more valuable than a $15,000 campaign simply because it comes from a larger publisher.
The questions should be:
How many people saw it?
How many engaged with it?
How many heard the message repeatedly?
How long did they spend with the content?
Was the audience actually composed of pharmacists, pharmacy executives, owners, manufacturers, technology companies, payers and industry decision-makers?
And what did each meaningful exposure cost?
That is where specialized media can outperform much larger publishers.
PPN does not need to be the largest revenue-generating media company in pharmacy to deliver exceptional media value.
In fact, our size may be one of our greatest advantages.
Less overhead.
More specialization.
More flexibility.
More content amplification.
Long-form storytelling.
Repeated exposure.
And direct access to a deeply defined pharmacy audience.
For healthcare marketers planning 2026–2027 budgets, I would encourage one change in how media investments are evaluated:
Stop comparing media companies only by total followers and brand size. Start comparing cost per meaningful exposure, engagement per follower, content longevity and audience relevance.
When you look through that lens, Pharmacy Podcast Network is competing at a level far beyond what our revenue or company size would suggest.
We may be the smallest business in this group.
But pound-for-pound, Pharmacy Podcast Network is becoming one of the most effective digital media platforms in pharmacy.
That is the ratio that matters.
Comments